Between 1989 and 2012, 484 TP-IATs were performed at the University of Minnesota and University of Minnesota Amplatz Children’s Hospital. Of these, 75 were done in children and formed the study population. Our criteria for selection of patients with CP for TP-IAT has evolved over the years and have been standardized for the last 5 years.17 (link) Currently, to qualify for TP-IAT, the patient must have had abdominal pain of > 6 months duration with impaired quality of life e.g., inability to attend school, inability to participate in ordinary activities, repeated hospitalizations, or constant need for narcotics, each coupled with failure to respond to maximal medical treatment or endoscopic pancreatic duct drainage procedures. In addition, there must be objective findings of CP, including at least one of the following: (1) pancreas calcifications on CT scan, or abnormal ERCP, or ≥ 6/9 criteria on endoscopic ultrasound( EUS); or (2) any two of following three: (1) ductal or parenchymal abnormalities on secretin stimulated magnetic resonance cholangiopancreatography (MRCP), EUS of pancreas with 6/9 criteria positive, or abnormal pancreatic function tests with peak bicarbonate < 80 mmol/L).; or (2) Histopathologic confirmed diagnosis of chronic pancreatitis from previous operations; or (3) Hereditary pancreatitis (PRSS1 gene mutation, (SPINK1 gene mutation, CFTR gene mutations), with a compatible clinical history ; or (4) History of recurrent acute pancreatitis with > 3 episodes of pain associated with imaging diagnostic of acute pancreatitis and/or elevated serum amylase or lipase 3 times normal.17 (link)The current study was approved by the University of Minnesota Institutional Review Board. Informed consent and assent were obtained from parents and patients for all patients participating in quality of life assessments.
>
Procedures
>
Diagnostic Procedure
>
Cholangiopancreatography, Magnetic Resonance
Cholangiopancreatography, Magnetic Resonance
Magnetic Resonance Cholangiopancreatography (MRCP) is a non-invasive imaging technique used to visualize the bile and pancreatic ducts.
It utilizes magnetic resonance imaging (MRI) to generate detailed images of the hepatobiliary and pancreatic system, allowing for the evaluation of various conditions affecting these structures.
MRCP is particularly useful in the diagnosis of biliary tract diseases, pancreatic disorders, and other hepatobiliary pathologies.
The PubCompare.ai platform helps researchers optimize their MRCP research workflow by providing intelligent protocol comparisons from literature, pre-prints, and patents, ensuring they discover the most effective solutions for their studies.
This AI-driven approach enhances the accuracy and efficiency of MRCP research, leading to improved patient outcomes.
It utilizes magnetic resonance imaging (MRI) to generate detailed images of the hepatobiliary and pancreatic system, allowing for the evaluation of various conditions affecting these structures.
MRCP is particularly useful in the diagnosis of biliary tract diseases, pancreatic disorders, and other hepatobiliary pathologies.
The PubCompare.ai platform helps researchers optimize their MRCP research workflow by providing intelligent protocol comparisons from literature, pre-prints, and patents, ensuring they discover the most effective solutions for their studies.
This AI-driven approach enhances the accuracy and efficiency of MRCP research, leading to improved patient outcomes.
Most cited protocols related to «Cholangiopancreatography, Magnetic Resonance»
Abdominal Pain
Acidic Pancreatic Trypsin Inhibitor
Bicarbonates
Child
Cholangiopancreatography, Magnetic Resonance
Congenital Abnormality
Cystic Fibrosis Transmembrane Conductance Regulator
Diagnosis
Drainage
Endoscopic Retrograde Cholangiopancreatography
Ethics Committees, Research
Hereditary pancreatitis
Hospitalization
Hyperamylasemia
Lipase
Mutation
Narcotics
Pain
Pancreas
Pancreatic Duct
Pancreatic Function Test
Pancreatitis, Acute
Parent
Patients
Physiologic Calcification
PRSS1 protein, human
Secretin
Serum
Surgical Endoscopy
X-Ray Computed Tomography
Abdomen
Cholangiopancreatography, Magnetic Resonance
Disease Progression
Endoscopic Retrograde Cholangiopancreatography
Ethics Committees, Research
Genetic Predisposition to Disease
Hereditary pancreatitis
Pancreatic Diseases
Pancreatitis
Patients
Physiologic Calcification
Radionuclide Imaging
Replicon
X-Ray Computed Tomography
This study was approved by the Institutional Review Board of our Hospital. Informed consent was signed by the guardians of each child. We retrospectively reviewed the medical records of 75 patients with PBM (24 males; 51 females; age range 2 months to 13 years) who were hospitalized between January 2002 and December 2011. The gold standard for the selection of PBM patients was defined as >5 mm common channel as detected by MRCP, intraoperative cholangiography and CT [4 (link)]. PBM was classified based on Komi’s method [5 ] to the following three types: type I joining of common bile duct with pancreatic duct at approximately 90°, type II joining of pancreatic duct with common bile duct usually at 90°, type III complex arrangement of pancreatic duct and terminal portion of common bile duct.
All patients underwent intraoperative cholangiography. Computed tomography (CT; Philips, Amsterdam, Netherlands) was performed using the anteroposterior projection with the child lying supine. The CT protocols and technical parameters included 5 mm collimation at 10 mm intervals. Ultrasonography (US) (LOGIQ 5 PRO; GE Healthcare, Little Chalfont, UK) was carried out with 5–12 MHz curved and linear abdominal transducers. Magnetic resonance cholangiopancreatography (MRCP) was performed (under sedation for subjects at <10 years of age) on a Symphony 1.5 T scanner (Siemens, Erlangen, Germany) with an abdominal phased array coil under the following modes: T1-weighted and T1-weighted fast spin series (field of view 24–28 cm, repetition time [TR] 173 ms, echo time [TE] 2.64 ms, flip angle 70, matrix 256 × 128, radiofrequency (RF) bandwidth 260 Hz/Px) and a T2-weighted sequence (TR 1,000 ms, TE 60 ms, RF bandwidth 230 Hz/Px). For MRCP, half fourier acquisition single shot turbo spin echo (HASTE) was used with multilayer thin coronal and axial T2-weighted imaging (TR 1,200 ms, TE 80 ms, slice thickness 4 mm). Oblique thick slabs were acquired in the planes of the common bile duct and pancreatic duct. For multi-angle imaging, TR was 4,500 ms, TE 950 ms and slice thickness 60 mm.
Two radiologists who were unaware of the pathological findings independently reviewed the images and reached consensus through discussion. A diagnosis of PBM was established if the common channel is longer than 5 mm. They also assess the shape of the intrahepatic bile duct and gallbladder, pancreatitis, surgical pathology, symptom profiles, operative notes and pathological records were compared with the imaging findings.
All patients underwent intraoperative cholangiography. Computed tomography (CT; Philips, Amsterdam, Netherlands) was performed using the anteroposterior projection with the child lying supine. The CT protocols and technical parameters included 5 mm collimation at 10 mm intervals. Ultrasonography (US) (LOGIQ 5 PRO; GE Healthcare, Little Chalfont, UK) was carried out with 5–12 MHz curved and linear abdominal transducers. Magnetic resonance cholangiopancreatography (MRCP) was performed (under sedation for subjects at <10 years of age) on a Symphony 1.5 T scanner (Siemens, Erlangen, Germany) with an abdominal phased array coil under the following modes: T1-weighted and T1-weighted fast spin series (field of view 24–28 cm, repetition time [TR] 173 ms, echo time [TE] 2.64 ms, flip angle 70, matrix 256 × 128, radiofrequency (RF) bandwidth 260 Hz/Px) and a T2-weighted sequence (TR 1,000 ms, TE 60 ms, RF bandwidth 230 Hz/Px). For MRCP, half fourier acquisition single shot turbo spin echo (HASTE) was used with multilayer thin coronal and axial T2-weighted imaging (TR 1,200 ms, TE 80 ms, slice thickness 4 mm). Oblique thick slabs were acquired in the planes of the common bile duct and pancreatic duct. For multi-angle imaging, TR was 4,500 ms, TE 950 ms and slice thickness 60 mm.
Two radiologists who were unaware of the pathological findings independently reviewed the images and reached consensus through discussion. A diagnosis of PBM was established if the common channel is longer than 5 mm. They also assess the shape of the intrahepatic bile duct and gallbladder, pancreatitis, surgical pathology, symptom profiles, operative notes and pathological records were compared with the imaging findings.
Abdomen
Bile
Child
Cholangiography
Cholangiopancreatography, Magnetic Resonance
Choledochus
CT protocol
Diagnosis
ECHO protocol
Electron Transport Complex III
Ethics Committees, Research
Females
Gallbladder
Gold
Intrahepatic Bile Duct
Legal Guardians
Males
Pancreatic Duct
Pancreatitis
Patients
Radiologist
Sedatives
Transducers
Ultrasonography
X-Ray Computed Tomography
Cholangiopancreatography, Magnetic Resonance
Endoscopic Retrograde Cholangiopancreatography
Pancreatitis
Patients
Physicians
Physiologic Calcification
Radionuclide Imaging
Ultrasonography, Endoscopic
X-Ray Computed Tomography
Abdominal Pain
Acidic Pancreatic Trypsin Inhibitor
Bicarbonates
Cholangiopancreatography, Magnetic Resonance
Congenital Abnormality
Cystic Fibrosis Transmembrane Conductance Regulator
Diagnosis
Drainage
Endoscopic Retrograde Cholangiopancreatography
Ethics Committees, Research
Hereditary pancreatitis
Hospitalization
Hyperamylasemia
Lipase
Mutation
Narcotics
Pain
Pancreas
Pancreatic Duct
Pancreatic Function Test
Pancreatitis
Pancreatitis, Acute
Pancreatitis, Chronic
Patients
Physiologic Calcification
PRSS1 protein, human
Reproduction
Secretin
Serum
Surgical Endoscopy
X-Ray Computed Tomography
Most recents protocols related to «Cholangiopancreatography, Magnetic Resonance»
All patients complained of abdominal pain. They were diagnosed with choledocholithiasis through magnetic resonance cholangiopancreatography. Informed consent was obtained from the patients for the publication of this case’s report details.
Abdominal Pain
Cholangiopancreatography, Magnetic Resonance
Choledocholithiasis
Patients
PSC is progressive biliary fibrosis affecting intra and/or extrahepatic bile ducts[12 (link)] and diagnosed by laboratory tests [(cholestasis, Antineutrophil cytoplasmic antibodies (ANCA)], radiology [abdominal ultrasonography (US), abdominal computed tomography (CT), endoscopic retrograde cholangiopancreatography (ERCP), or magnetic resonance cholangiopancreatography (MRCP)], and liver biopsy. Primary biliary cholangitis (PBC) is characterized by the loss of small and medium-sized bile ducts on liver biopsy, elevated anti-mitochondrial antibodies, and altered gamma-glutamyl transferase and alkaline phosphatase (ALP) levels[13 (link)]. Non-alcoholic fatty liver disease (NAFLD) is characterized by fat storage in ≥ 5% of hepatic steatosis in the absence of concomitant liver disease (chronic viral hepatitis), use of steatosis-inducing medications (amiodarone or tamoxifen), autoimmune hepatitis, hemochromatosis, Wilson's disease, or excessive alcohol consumption[14 (link)]. Diagnosis of NAFLD was made by liver biopsies or US[15 (link)], and the severity score was previously stated[16 (link)]. Autoimmune hepatitis diagnosis based on the International Autoimmune Hepatitis Group criteria with a score of > 15 points consisting of demographic, histologic, and laboratory markers, including antinuclear antibodies with a titer of at least 1:40 and liver histology[17 (link)]. An aseptic liver abscess is diagnosed based on IBD history, US, and CT[18 (link)]. Ultrasound, colour Doppler, and/or CT scans were used to detect portal vein thrombosis.
Abdomen
Alkaline Phosphatase
Amiodarone
Anti-Antibodies
Antibodies, Antinuclear
Antineutrophil Cytoplasmic Antibodies
Asepsis
Autoimmune Chronic Hepatitis
Bile
Bile Ducts, Extrahepatic
Biopsy
Cholangiopancreatography, Magnetic Resonance
Cholestasis
Duct, Bile
Endoscopic Retrograde Cholangiopancreatography
Fatty Liver
Fibrosis
gamma-Glutamyl Transpeptidase
Hemochromatosis
Hepatic Duct
Hepatitis, Chronic
Hepatolenticular Degeneration
Liver
Liver Abscess
Liver Diseases
Mitochondria
Non-alcoholic Fatty Liver Disease
Pharmaceutical Preparations
Primary Biliary Cholangitis
Radiography
Radionuclide Imaging
Steatohepatitis
Tamoxifen
Thrombosis
Ultrasonography
Veins, Portal
Venous Thrombosis
X-Ray Computed Tomography
For histological assessment, a cross-sectional sample of distal donor bile duct was taken at the end of cold ischemia just before liver implantation. Specimens were processed in 10% neutral buffered formalin and stained in hematoxylin and eosin. They were examined independently by 2 blinded hepatobiliary pathologists‚ and discrepancies in scores were resolved with multiheader consensus. Bile duct injury was scored using a bile duct injury scoring system as described by Op den Dries et al.4 (link) This is a semiquantitative systematic histological scoring system for bile duct injury that examines the biliary epithelium, mural stroma, vascular plexus, peribiliary glands, inflammation, bleeding‚ and thrombosis within bile duct samples. This histological scoring system has been shown to correlate with biliary complications.4 (link)Recipients were managed intraoperatively and postoperatively in the standard fashion at the ANLTU. Recipients were followed up for 24 mo‚ and medical records were comprehensively reviewed for outcome data. The clinical endpoint was biliary complications occurring within 24 mo from transplantation. Biliary complications were diagnosed by clinical or biochemical suspicion, and routine imaging was not performed because of low diagnostic yield in asymptomatic patients.15 (link) No threshold for liver biochemistry was used to trigger biliary investigation. Biliary complications included biliary strictures and bile leaks. Biliary strictures were defined as any narrowing of the donor biliary tree on magnetic resonance cholangiopancreatography or endoscopic retrograde cholangiopancreatography.16 (link),17 (link) Not all cases of biliary strictures underwent endoscopic retrograde cholangiopancreatography because of anatomic location or severity of clinical symptoms. Biliary strictures were subcategorized into anastomotic strictures (AS) and non-AS (NASs). AS was defined as strictures localized to the biliary anastomosis. NAS was defined as any stricture in the donor biliary tree away from the biliary anastomosis. Bile leak was defined as the presence of bilirubin in the posttransplant drain or extravasation of bile on biliary imaging.
This trial was prospectively registered on the Australian and New Zealand Clinical Trials Registry (U1111-1179-9801) and approved by the Sydney Local Health District Ethics Review Committee (Approval Number X15-0444).
This trial was prospectively registered on the Australian and New Zealand Clinical Trials Registry (U1111-1179-9801) and approved by the Sydney Local Health District Ethics Review Committee (Approval Number X15-0444).
Bile
Bilirubin
Blood Vessel
Cholangiopancreatography, Magnetic Resonance
Desiccation
Diagnosis
Donors
Duct, Bile
Endoscopic Retrograde Cholangiopancreatography
Eosin
Epithelium
Formalin
Inflammation
Injuries
Ischemia, Cold
Liver
Ovum Implantation
Pathologists
Patients
Precipitating Factors
Stenosis
Surgical Anastomoses
System, Biliary
Thrombosis
Transplantation
Prospectively collected data of all patients who underwent extended hepatectomy at the department of surgical gastroenterology from October 2012 to April 2022 were analyzed retrospectively. Ethical approval to conduct the study was obtained from the Institutional Review Committee of the Institute of Medicine with reference number 210(6-11)E2.
Preoperative assessment
The standard preoperative assessment included a detailed history and physical examination, hematological and biochemical investigations including liver function test, hepatitis B/C status, biomarkers (mainly CEA, CA19.9, and AFP), ultrasonography of the abdomen, and contrast-enhanced computer tomography (CECT) of the abdomen with liver volumetric assessment. Magnetic resonance cholangiopancreatography (MRCP) was done in selected patients requiring assessment of biliary tract anatomy like hilar cholangiocarcinoma. Patients presenting with biliary obstruction and cholangitis had biliary drainage using percutaneous transhepatic biliary drainage (PTBD) to decrease the level of bilirubin and resolve cholangitis.
A standard FLR (sFLR) was calculated in all patients by measuring the ratio of CT-measured FLR with total estimated liver volume (TELV) by using the formula TELV= -794.41 + 1267.28 X BSA) [6 (link)]. More than 25% of sFLR was considered safe. Patients with low FLR underwent liver augmentation by either portal vein embolization (PVE) (Fig1 ), portal vein ligation (PVL), or partial ALPPS. A repeat CT scan was done in three weeks in cases with PVE and 10 days in cases with partial ALPPS to assess the extent of compensatory liver hypertrophy. A surgical decision was then made based on CT volumetry.
Surgical techniques
Staging laparoscopy was done in selected cases of malignancy (a total of 10 cases, six cases of carcinoma gallbladder, and two cases of hilar cholangiocarcinoma). A modified Makuuchi incision was given in all cases. Complete mobilization of the liver was done and inflow and outflow control were taken. Parenchymal transection was aided by a Hanging maneuver [7 (link)]. Transaction techniques (Kelly-clysis, harmonic scalpel, or monopolar cautery) were at the surgeon’s discretion. After completion of the transection, bilioenteric anastomosis was done by Roux en Y hepaticojejunostomy.
For patients undergoing partial ALPPS, first-stage surgery was partial transection of liver parenchyma along with ligation of the right portal vein. Second-stage surgery comprises of completion of the transection with Roux-en-Y hepaticojejunostomy (Figure2 ).
Data collection
All variables (demographics, intraoperative, and postoperative) that were recorded in the departmental database were reviewed. Missing data were obtained from hospital record files. The 30-day postoperative outcomes including follow up were reviewed.
Outcomes and definitions
The outcomes measured were overall and hepatectomy-specific complications, a comparison of postoperative outcomes among the liver volume augmentation group versus no augmentation group, and perioperative factors affecting major complications. Hepatectomy-specific complications like PHLF and bile leak were defined as per the International Study Group of Liver Surgery (ISGLS) 2011 [8 (link)-9 (link)]. Small-for-size syndrome (SFSS) for extended hepatectomy was defined by the University of Heidelberg (2015) [10 (link)]. Other complications were defined and graded as per the Clavein Dindo grading system [11 (link)]. Perioperative mortality was defined as mortality within 30 days of surgery.
Statistical analysis
We analyzed data using SPSS version 25 (IBM Corp., Armonk, NY). Data were presented in numbers, mean ± SD, and percentages where appropriate. The correlation between variables was analyzed using Fischer’s exact test for categorical variables and sample t-test for continuous variables. A p-value of <0.05 was taken as statistically significant.
Preoperative assessment
The standard preoperative assessment included a detailed history and physical examination, hematological and biochemical investigations including liver function test, hepatitis B/C status, biomarkers (mainly CEA, CA19.9, and AFP), ultrasonography of the abdomen, and contrast-enhanced computer tomography (CECT) of the abdomen with liver volumetric assessment. Magnetic resonance cholangiopancreatography (MRCP) was done in selected patients requiring assessment of biliary tract anatomy like hilar cholangiocarcinoma. Patients presenting with biliary obstruction and cholangitis had biliary drainage using percutaneous transhepatic biliary drainage (PTBD) to decrease the level of bilirubin and resolve cholangitis.
A standard FLR (sFLR) was calculated in all patients by measuring the ratio of CT-measured FLR with total estimated liver volume (TELV) by using the formula TELV= -794.41 + 1267.28 X BSA) [6 (link)]. More than 25% of sFLR was considered safe. Patients with low FLR underwent liver augmentation by either portal vein embolization (PVE) (Fig
Surgical techniques
Staging laparoscopy was done in selected cases of malignancy (a total of 10 cases, six cases of carcinoma gallbladder, and two cases of hilar cholangiocarcinoma). A modified Makuuchi incision was given in all cases. Complete mobilization of the liver was done and inflow and outflow control were taken. Parenchymal transection was aided by a Hanging maneuver [7 (link)]. Transaction techniques (Kelly-clysis, harmonic scalpel, or monopolar cautery) were at the surgeon’s discretion. After completion of the transection, bilioenteric anastomosis was done by Roux en Y hepaticojejunostomy.
For patients undergoing partial ALPPS, first-stage surgery was partial transection of liver parenchyma along with ligation of the right portal vein. Second-stage surgery comprises of completion of the transection with Roux-en-Y hepaticojejunostomy (Figure
Data collection
All variables (demographics, intraoperative, and postoperative) that were recorded in the departmental database were reviewed. Missing data were obtained from hospital record files. The 30-day postoperative outcomes including follow up were reviewed.
Outcomes and definitions
The outcomes measured were overall and hepatectomy-specific complications, a comparison of postoperative outcomes among the liver volume augmentation group versus no augmentation group, and perioperative factors affecting major complications. Hepatectomy-specific complications like PHLF and bile leak were defined as per the International Study Group of Liver Surgery (ISGLS) 2011 [8 (link)-9 (link)]. Small-for-size syndrome (SFSS) for extended hepatectomy was defined by the University of Heidelberg (2015) [10 (link)]. Other complications were defined and graded as per the Clavein Dindo grading system [11 (link)]. Perioperative mortality was defined as mortality within 30 days of surgery.
Statistical analysis
We analyzed data using SPSS version 25 (IBM Corp., Armonk, NY). Data were presented in numbers, mean ± SD, and percentages where appropriate. The correlation between variables was analyzed using Fischer’s exact test for categorical variables and sample t-test for continuous variables. A p-value of <0.05 was taken as statistically significant.
Abdomen
Bile
Bilirubin
Biological Markers
CA-19-9 Antigen
Cancer of Gallbladder
Cauterization
Cholangiopancreatography, Magnetic Resonance
Cholangitis
Cholestasis
Drainage
Embolization, Therapeutic
Hepatectomy
Hepatitis C virus
Klatskin Tumor
Laparoscopy
Ligation
Liver
Liver Function Tests
Malignant Neoplasms
Operative Surgical Procedures
Patients
Physical Examination
Roux-en-Y Anastomosis
Surgeons
Surgical Anastomoses
Syndrome
System, Biliary
Tomography
Tomography, Spiral Computed
Ultrasonography
Veins, Portal
X-Ray Computed Tomography
A retrospective study was done utilizing the preoperative planning magnetic resonance cholangiopancreatography (MRCP) performed for living donor liver transplantation (LDLT). Sixty-five donor MRCP examinations performed for LDLT between January 2013 and July 2018 at the Global Hospitals Group (Chennai and Bengaluru, India) and Aster Medcity (Kochi, India) were studied retrospectively to evaluate the frequency of anatomical variations of the biliary tree. The age group of the donors was in the range of 20 to 51 years. A total of 105 MRCP studies performed for potential liver donors during the period were evaluated. We excluded 25 MRCP studies as there were no intraoperative cholangiograms available for us to compare, and we also excluded an additional 15 MRCP studies that had respiratory movement artifacts that prevented us from having a meaningful interpretation. The remaining 65 MRCP examinations were included in the study.
Inclusion and Exclusion Criteria
All the completed MRCP studies, without significant respiratory movement artifacts, performed as a part of the preoperative planning protocol for LDLT were included in the study. Donors who were not able to complete the study or whose images contained respiratory movement artifacts impeding accurate interpretation were excluded. We also excluded donors if the intraoperative cholangiogram images were not made available for us to compare.
The institutional review board approved the retrospective study. Informed consent was waived.
As a part of the pre-transplantation donor workup, MRI with MRCP was performed on a 1.5T MRI GE machine for all these candidates. A single-shot fast spin echo sequence (SSFSE, GE Medical Systems) was performed for all the donors after the planning sequences. A respiratory-gated three-dimensional turbo spin echo sequence was also performed that offered a high signal-to-noise ratio, improved spatial resolution, and high contrast-to-noise ratio. Each donor received a phased-array body coil. We preferred to do the procedure after an overnight fast. Sometimes, we also gave pineapple juice to the donors as an oral negative contrast for a better appreciation of the biliary tract.
MRCP source data sets were processed with maximum intensity projections, surface shading, and multi-planar reconstructions. The images were reviewed by two radiologists and compared with an intraoperative cholangiogram. Intraoperative cholangiograms performed via cystic duct cannulation were considered the gold standard. Sensitivity, specificity, and accuracy were calculated based on the findings.
Inclusion and Exclusion Criteria
All the completed MRCP studies, without significant respiratory movement artifacts, performed as a part of the preoperative planning protocol for LDLT were included in the study. Donors who were not able to complete the study or whose images contained respiratory movement artifacts impeding accurate interpretation were excluded. We also excluded donors if the intraoperative cholangiogram images were not made available for us to compare.
The institutional review board approved the retrospective study. Informed consent was waived.
As a part of the pre-transplantation donor workup, MRI with MRCP was performed on a 1.5T MRI GE machine for all these candidates. A single-shot fast spin echo sequence (SSFSE, GE Medical Systems) was performed for all the donors after the planning sequences. A respiratory-gated three-dimensional turbo spin echo sequence was also performed that offered a high signal-to-noise ratio, improved spatial resolution, and high contrast-to-noise ratio. Each donor received a phased-array body coil. We preferred to do the procedure after an overnight fast. Sometimes, we also gave pineapple juice to the donors as an oral negative contrast for a better appreciation of the biliary tract.
MRCP source data sets were processed with maximum intensity projections, surface shading, and multi-planar reconstructions. The images were reviewed by two radiologists and compared with an intraoperative cholangiogram. Intraoperative cholangiograms performed via cystic duct cannulation were considered the gold standard. Sensitivity, specificity, and accuracy were calculated based on the findings.
Age Groups
Anatomic Variation
Aster Plant
Cannulation
Cholangiography
Cholangiopancreatography, Magnetic Resonance
Donors
Ducts, Cystic
ECHO protocol
Ethics Committees, Research
Gold
Human Body
Hypersensitivity
Liver
Liver Transplantations
Living Donors
Movement
Physical Examination
Pineapple
Radiologist
Reconstructive Surgical Procedures
Respiratory Rate
System, Biliary
Transplantation
Vibration
Top products related to «Cholangiopancreatography, Magnetic Resonance»
Sourced in Netherlands, Germany, United States, Switzerland, Japan
The Philips Ingenia is a magnetic resonance imaging (MRI) system designed for diagnostic imaging. It provides high-quality images of the body's internal structures to aid in the detection and diagnosis of various medical conditions.
Sourced in Netherlands, United States, Germany
The Philips Achieva 3.0T is a magnetic resonance imaging (MRI) system that operates at a magnetic field strength of 3.0 Tesla. It is designed to capture high-quality images of the human body for diagnostic purposes.
Sourced in United States
The Signa HDxt V16.0 is a magnetic resonance imaging (MRI) system developed by GE Healthcare. It is designed to provide high-quality imaging capabilities for healthcare professionals. The core function of the Signa HDxt V16.0 is to acquire and process MRI data, enabling the visualization of internal body structures and functions.
Sourced in Germany
Gd-DTPA is a paramagnetic contrast agent used in magnetic resonance imaging (MRI) procedures. It contains the element gadolinium (Gd) chelated with the organic compound diethylenetriaminepentaacetic acid (DTPA). Gd-DTPA enhances the contrast of images in MRI scans by altering the magnetic properties of nearby water molecules, allowing for improved visualization of tissues and structures within the body.
Sourced in Germany, United States, Japan, China, United Kingdom, Jersey, Canada, Ireland
Magnevist is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) procedures. It is designed to enhance the visualization of internal body structures and improve the diagnostic capabilities of MRI scans.
Sourced in Japan
The CV-290 is a laboratory centrifuge designed for general-purpose use. It features a high-speed motor capable of generating centrifugal forces up to 4,000 x g. The centrifuge is compatible with a wide range of sample containers and can accommodate volumes up to 290 milliliters. The system is equipped with a digital speed and time control interface for precise operation.
Sourced in United States, United Kingdom, Japan, Belgium, India
SPSS software version 23.0 is a statistical analysis software package developed by IBM. It is designed to analyze and manage data, perform a variety of statistical analyses, and generate reports. The software provides tools for data manipulation, descriptive statistics, bivariate statistics, prediction for numerical outcomes, and prediction for identifying groups.
Sourced in Japan, United States
Synapse 3D is a software solution developed by Fujifilm for medical image visualization and analysis. It provides healthcare professionals with tools to view, manipulate, and analyze three-dimensional medical images, such as those obtained from CT, MRI, and PET scans. The software is designed to enhance diagnostic capabilities and support clinical decision-making.
Sourced in United States
SPSS version 21 is a statistical software package designed to analyze data and present results. It provides a range of analytical tools for data management, data analysis, and reporting. SPSS version 21 is used to perform various statistical procedures, including descriptive statistics, correlations, regression analysis, and hypothesis testing.
Sourced in Germany
The 3.0 Tesla scanner is a magnetic resonance imaging (MRI) device that generates a strong magnetic field of 3.0 Tesla for advanced imaging of the human body. It is designed to capture high-resolution anatomical images and provide detailed information about the structure and function of various organs and tissues.
More about "Cholangiopancreatography, Magnetic Resonance"
Magnetic Resonance Cholangiopancreatography (MRCP) is a non-invasive imaging technique that utilizes magnetic resonance imaging (MRI) to generate detailed visualizations of the bile and pancreatic ducts.
This advanced modality, also known as MR Cholangio-Pancreatography, is particularly useful for the evaluation of various hepatobiliary and pancreatic conditions, including biliary tract diseases, pancreatic disorders, and other pathologies affecting these structures.
The MRCP procedure involves the use of specialized MRI equipment, such as the Ingenia, Achieva 3.0T, or Signa HDxt V16.0 systems, to capture high-quality images of the hepatobiliary and pancreatic systems.
During the imaging process, a contrast agent, such as Gd-DTPA (Magnevist) or CV-290, may be administered to enhance the visualization of the ducts and associated structures.
The resulting MRCP images can be analyzed using advanced software tools, like Synapse 3D, to aid in the diagnosis and management of a wide range of conditions.
The data can also be processed and interpreted using statistical analysis software, such as SPSS version 23.0 or 21.0, to gain deeper insights and support research efforts.
The PubCompare.ai platform leverages artificial intelligence to assist researchers in optimizing their MRCP research workflow.
By providing intelligent protocol comparisons from literature, pre-prints, and patents, the platform helps users discover the most effective solutions for their studies, ultimately enhancing the accuracy and efficiency of MRCP research and leading to improved patient outcomes.
This advanced modality, also known as MR Cholangio-Pancreatography, is particularly useful for the evaluation of various hepatobiliary and pancreatic conditions, including biliary tract diseases, pancreatic disorders, and other pathologies affecting these structures.
The MRCP procedure involves the use of specialized MRI equipment, such as the Ingenia, Achieva 3.0T, or Signa HDxt V16.0 systems, to capture high-quality images of the hepatobiliary and pancreatic systems.
During the imaging process, a contrast agent, such as Gd-DTPA (Magnevist) or CV-290, may be administered to enhance the visualization of the ducts and associated structures.
The resulting MRCP images can be analyzed using advanced software tools, like Synapse 3D, to aid in the diagnosis and management of a wide range of conditions.
The data can also be processed and interpreted using statistical analysis software, such as SPSS version 23.0 or 21.0, to gain deeper insights and support research efforts.
The PubCompare.ai platform leverages artificial intelligence to assist researchers in optimizing their MRCP research workflow.
By providing intelligent protocol comparisons from literature, pre-prints, and patents, the platform helps users discover the most effective solutions for their studies, ultimately enhancing the accuracy and efficiency of MRCP research and leading to improved patient outcomes.